Skip to content

Effects of System-wide Intervention Strategy for Implementing Recommended Care versus Recommended Care Alone on hospitalization-based Venous Thromboembolism Prophylaxis in China: A Cluster-Randomized Clinical Trial

Effects of Various System-wide Interventions for Implementing Recommended Care versus Recommended Care Alone on Venous Thromboembolism Prophylaxis among Hospitalized Patients in China: A Cluster-Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021234
Enrollment
Unknown
Registered
2019-02-02
Start date
2019-04-30
Completion date
Unknown
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thromboembolism

Interventions

Intervention Group:system-wide intervention strategy plus recommended care+ recommended care
Control Group:recommended care only

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Inclusions for hospitals: (1) Tertiary hospitals with > 500 beds that provide high-level services, medical education, and research; (2) Willingness to participate in this program hospitals. 2. Inclusions for patients: (1) Adult medical and surgical patients aged =18 years; (2) Length of stay =3 days; (3) Local residents who would be accessible and available during the study; (4) Patients from general medicine, cardiac, neurovascular, oncology, respiratory, rheumatic, and the general surgical and orthopedic wards were included.

Exclusion criteria

Exclusion criteria: 1. Exclusions for hospitals: Specialized hospitals, e.g., pediatric, maternal and infants, surgery hospitals or Traditional Chinese Medicine hospitals. 2. Exclusions for patients: (1) Patients who are receiving therapeutic anticoagulation-current patients; (2) Patients hospitalized for VTE at admission or VTE is diagnosed within 48 hours following admission to rule out VTE that had occurred before hospital admission; (3) Patients who have participated in similar trials or are undergoing other clinical trials; (4) Patients from the following wards were excluded: psychiatric; maternity; pediatric; ear, nose, and throat; burn; dermatology; ophthalmology; chronic; rehabilitation; and palliative care; (5) Patients who are not willing to sign the consent form.

Design outcomes

Primary

MeasureTime frame
Prophylaxis rate;

Countries

China

Contacts

Public ContactZhenguo Zhai

China-Japan Friendship Hospital

zhaizhenguo2011@126.com+86 18611706133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026